J. M. Blondeau*, M. Suter, S. Borsos and the Canadian Antimicrobial Study Group
|
|
- Harriet Banks
- 5 years ago
- Views:
Transcription
1 Journal of Antimicrobial Chemotherapy (1999) 43, Suppl. A, JAC Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis J. M. Blondeau*, M. Suter, S. Borsos and the Canadian Antimicrobial Study Group Division of Clinical Microbiology, Saskatoon District Health and St Paul s Hospital (Grey Nuns) and the Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada The susceptibility of Canadian isolates of three respiratory tract pathogens (Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae) to several antimicrobial agents were tested by two different methods. β-lactamase was produced by 68/211 (32.2%) of H. influenzae isolates and 64/75 (85.3%) of M. catarrhalis isolates. For S. pneumoniae, 19/156 (12.2%) isolates were resistant to penicillin (MIC 0.12 mg/l) and two isolates had MICs of 1.5 mg/l. For some combinations of agents and organisms, different methods gave different values for the proportion of isolates susceptible. Regardless of methodology, for H. influenzae, the most active antimicrobials based on proportion of strains susceptible were ciprofloxacin (100%) and cefpodoxime ( %). For M. catarrhalis, the most active agents were azithromycin, cefaclor, cefixime, cefpodoxime, cefuroxime, ciprofloxacin, clarithromycin and loracarbef (100% each); the least active was ampicillin. Against penicillin-sensitive and -resistant pneumococci, the activity was not significantly different for azithromycin and clarithromycin ( %) and ciprofloxacin (MIC and 1.5 mg/l, respectively) but was different for cefuroxime (99.3% and 31.6%, respectively), cefaclor (MIC and 256 mg/l, respectively), cefpodoxime (MIC and 1.5 mg/l, respectively) and loracarbef (MIC and 256 mg/l, respectively). This study indicates the increasing incidence, in Canada, of β-lactamase resistance in H. influenzae and M. catarrhalis and penicillin resistance in S. pneumoniae. Introduction Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis are responsible for systemic as well as upper and lower respiratory tract infections including otitis media, sinusitis and community-acquired pneumonia. 1 3 In addition, H. influenzae and S. pneumoniae are frequently implicated as bacterial causes of meningitis, although the incidence of the former is decreasing. Treatment of these potentially serious infections has become problematic because of increasing global antimicrobial resistance. 4 6 Surveillance studies to detect and monitor antimicrobial resistance are now, therefore, needed. Recent publications suggest increasing resistance amongst H. influenzae, S. pneumoniae and M. catarrhalis to a variety of antimicrobial agents. 1,2,7 10 The methodology and interpretation used for susceptibility testing may influence the results and, therefore, resistance rates for some pathogens and antimicrobial agents. 4,11 In this study, we report the in-vitro susceptibilities of these commonly isolated respiratory pathogens, collected from Canadian laboratories, to several currently available antimicrobial agents using two different methods. Materials and methods Bacterial strains Isolates of H. influenzae, S. pneumoniae and M. catarrhalis from clinical specimens were collected from community and teaching hospitals during 1993 and All isolates were sent to the study coordinator (J.M.B.) and tested at St *Corresponding address: Department of Clinical Microbiology, Royal University Hospital, 103 Hospital Drive, Saskatoon, Saskatchewan, Canada, S7N 0W8. Tel: ; Fax: ; blondeauj@sdh.sk.ca See Acknowledgements The British Society for Antimicrobial Chemotherapy 25
2 J. M. Blondeau et al. Paul s Hospital, Saskatchewan, Canada. Isolates were identified as H. influenzae, S. pneumoniae or M. catarrhalis by standard methods and frozen at 70 C in skimmed milk or on latex beads (Pro Lab Diagnostics, Toronto, Canada) until testing. Before susceptibility testing, isolates were subcultured on to chocolate agar plates (PML, Richmond, Canada) and incubated at 37 C in 5% CO 2 for h. Duplicate isolates from the same patients were excluded. Susceptibility testing All isolates of H. influenzae and M. catarrhalis were tested for β-lactamase production with a nitrocefinase disc test (Cefinase; BBL Microbiology Systems, Cockeysville, MD, USA). MICs for all isolates were determined by two different methods: Etest (AB Biodisk, Solna, Sweden) and Kirby Bauer disc diffusion methodology. For both methods, a suspension of the test organism equivalent to a 0.5 McFarland standard was prepared and 150 mm diameter Mueller Hinton agar plates, supplemented with sheep blood were inoculated, using a non-toxic swab, to produce confluent growth. Etest strips or discs containing the antimicrobial agent were placed on the inoculated plates with sterile forceps. For isolates of H. influenzae and M. catarrhalis, susceptibility to ampicillin, azithromycin, cefaclor, cefixime, cefpodoxime, cefuroxime, clarithromycin, loracarbef and ciprofloxacin was determined. The susceptibility of S. pneumoniae to azithromycin, cefaclor, cefixime, cefpodoxime, cefuroxime, clarithromycin, loracarbef, oxacillin, penicillin and ciprofloxacin was determined. The plates were incubated for h at 35 C in 5% CO 2. For the Etest, MICs were recorded at the point where growth of the micro-organism intersected the Etest strip. For the Kirby Bauer method, the diameter of the zone of inhibition was measured. Susceptibility was defined as the percentage of isolates that were susceptible at the established NCCLS breakpoint. 13 Isolates with intermediate susceptibility were included with resistant isolates. For S. pneumoniae, MICs of penicillin of 0.12 mg/l were categorized as resistant. The following strains were used for quality control and tested each time susceptibility testing was performed: S. pneumo - niae ATCC 49619, H. influenzae ATCC and 49247, and M. catarrhalis ATCC Results The susceptibilities of 211 H. influenzae, 156 S. pneumoniae and 75 M. catarrhalis isolates were determined for the selected antimicrobial agents by Etest or the Kirby Bauer method. Table I shows the antimicrobial susceptibilities of β-lactamase-positive and -negative isolates of H. influen - zae. Of the 211 isolates, 68 (32.2%) were β-lactamasepositive. Of the 143 β-lactamase-negative isolates, 11 (7.7%) were judged to be resistant to ampicillin by the Kirby Bauer method ( 18 mm diameter) and seven (4.9%) by the Etest (MIC 4 mg/l). Of the β-lactams Table I. Antimicrobial susceptibility of 211 Haemophilus influenzae isolates collected from across Canada Etest MIC (mg/l) Susceptibility (%) Antimicrobial β-lactamase agent production n 50% 90% range Etest Kirby Bauer Ampicillin positive negative Azithromycin positive negative Cefaclor positive negative Cefixime positive 68 ND ND ND ND 95.6 negative 143 ND ND ND ND 97.9 Cefpodoxime positive negative Cefuroxime positive negative Clarithromycin positive negative Loracarbef positive negative Ciprofloxacin positive negative ND, Not done. 26
3 Susceptibilities of Canadian isolates tested, cefuroxime and cefpodoxime were the most active agents against both enzyme-producing and non-enzymeproducing isolates of H. influenzae. Excluding ampicillin and cefaclor, all β-lactams had resistance rates of 3.4%. The presence of β-lactamase in H. influenzae isolates had little effect on the in-vitro activities of azithromycin and clarithromycin. However, there were several differences between the results of the Etest and those of the Kirby Bauer method in terms of susceptibility to azithromycin and clarithromycin. Against β-lactamase-positive isolates, azithromycin susceptibility rates were found to be 85.3% and 100% by the Etest and Kirby Bauer method respectively, while the corresponding values for clarithromycin were 73.5% and 70.6%, respectively. A similar trend was seen for β-lactamase-negative isolates: azithromycin susceptibility was 93.0% and 100% according to the Etest and the Kirby Bauer method, respectively, while the values for clarithromycin were 77.6% and 83.2%, respectively. All isolates were highly susceptible (100%) to ciprofloxacin by both methods. Ten antimicrobial agents were tested against the S. pneu - moniae isolates (Table II). Using the Kirby Bauer method, 12.2% had elevated MICs of oxacillin. In addition, 12.2% of isolates were determined to be penicillin-resistant by the Etest. High-level ( 2.0 mg/l) penicillin resistance was not detected, although two (10.5%) of 19 isolates had MICs of 1.5 mg/l. Similar discrepancies between methods were also noted for all other β-lactam antimicrobials tested. Susceptibility results were more consistent between the Etest and Kirby Bauer methodologies for clarithromycin (97.8% and 96.9%, respectively), and azithromycin (93.4% and 96.9%, respectively), when tested against penicillin-sensitive isolates. For penicillin-resistant isolates, susceptibility to both azithromycin and clarithromycin was 100% and 96.6% as determined by the Etest and the Kirby Bauer method, respectively. Of the penicillin-sensitive isolates, 99.3% were susceptible to cefuroxime as determined by the Etest. For penicillin-resistant isolates, cefpodoxime was the β- lactam agent that retained good activity (Etest); the others had MIC 90 s ranging from 4.0 to 256 mg/l. The Kirby Bauer method failed to detect differences in resistance rates between penicillin-sensitive and penicillin-resistant isolates and cross-resistance to other agents when compared with the Etest. There was no difference in the activity of ciprofloxacin against penicillin-sensitive or penicillin-resistant isolates when using the Etest. Nine antimicrobial agents were tested against 75 isolates of M. catarrhalis (Table III). Overall, 85% of the isolates were β-lactamase-positive. According to the Etest, all of the β-lactamase-positive isolates were susceptible to all of the agents except ampicillin. The Kirby Bauer test indicated 95.3% susceptibility to cefuroxime, and 100% susceptibility for the remaining agents. There was little Table II. Antimicrobial susceptibility of 156 Streptococcus pneumoniae isolates collected from across Canada Etest MIC (mg/l) Susceptibility (%) Antimicrobial Penicillin agent susceptibility n 50% 90% range Etest Kirby Bauer Azithromycin sensitive resistant Cefaclor sensitive NA NA resistant NA NA Cefixime sensitive 137 ND ND ND ND NA resistant 19 ND ND ND ND NA Cefpodoxime sensitive NA NA resistant NA NA Cefuroxime sensitive NA resistant NA Clarithromycin sensitive resistant Loracarbef sensitive NA NA resistant NA NA Oxacillin sensitive NA 100 resistant NA? Penicillin sensitive resistant Ciprofloxacin sensitive NA NA resistant NA NA ND, not done; NA, no approved NCCLS breakpoint. 27
4 J. M. Blondeau et al. Table III. Antimicrobial susceptibility of 75 Moraxella catarrhalis isolates collected from across Canada Etest MIC (mg/l) Susceptibility (%) Antimicrobial β -Lactamase Agent production n 50% 90% range Etest Kirby Bauer Ampicillin positive NA negative NA Azithromycin positive negative Cefaclor positive negative Cefixime positive 64 ND ND ND ND 100 negative 11 ND ND ND ND 100 Cefpodoxime positive negative Cefuroxime positive negative Clarithromycin positive negative Loracarbef positive negative Ciprofloxacin positive negative ND, not done; NA, no approved NCCLS breakpoint available. evidence of non-β-lactamase-mediated resistance since the susceptibilities of β-lactamase-negative isolates tested were similar to those of β-lactamase-positive isolates. All β-lactamase-positive and -negative isolates were susceptible to ciprofloxacin by both methods. Discussion Trembley et al. 14 previously reported on the incidence of H. influenzae resistance to antimicrobial agents across Canada. Of isolates collected in , 16.9% were β- lactamase-positive, varying from 12.8% to 19.6% in different regions of Canada. In total, 19.3% of H. influenzae isolates were resistant to ampicillin, 3.8% to erythromycin, 1.4% to cefaclor and 0.7% to cefuroxime. The newer macrolide/azalide agents were not tested in the aforementioned study. Scriver et al. 1 reported on the susceptibility of H. influenzae isolates to 11 antimicrobial agents collected in 1992 and 1993 from 23 Canadian medical centres. Of 1688 isolates tested, 28.4% were β-lactamase-positive, and five (0.4%) isolates that were β-lactamase-negative were resistant to ampicillin. In the same study, resistance to cephalosporins was 3.5%, while erythromycin resistance was 90%. Hoban et al. 15 determined antimicrobial susceptibility to 263 H. influenzae isolates from 18 Canadian medical centres. They reported that 29% of isolates were resistant to ampicillin, and 12% to cefaclor. Hoban et al. 16 tested 1000 H. influenzae isolates from five medical centres in the USA and Canada and found that 33% were resistant to ampicillin, 10% to cefaclor and 1% to cefixime. In our study, we found that 32.2% of isolates were β-lactamasepositive and that from seven to 11 of the β-lactamasenegative isolates were ampicillin-resistant, the actual number depending on the susceptibility testing method used. Resistance to cephalosporins (except cefaclor), was 3.4%, a finding identical to that of Scriver et al.; 1 resistance to loracarbef was similar to that of the cephalosporins. Additionally, the newer macrolides had resistance rates ranging from 0% to 29.4% depending on the agent tested and the methodology used for interpretation. The incidence of pneumococcal resistance to several antimicrobial agents has increased over the past few years. 8,10,17 21 Resistant S. pneumoniae had been infrequently identified in Canada with three previous Canadian surveys reporting resistance rates of 1.5% to 2.4% Recently, Simor et al. 10 tested 1089 S. pneumoniae isolates collected from 39 laboratories across Canada. They found that 11.7% of the isolates had reduced susceptibility to penicillin: 8.4% with intermediate resistance and 3.3% with high-level resistance. The frequency of resistance was not uniform across the country, with resistance rates increasing from East to West. In agreement with this present study, they concluded that there has been a recent significant increase in the prevalence of antibiotic-resistant S. pneu - moniae in Canada. Jacobs et al. 25 evaluated the Etest method for determining the MICs of four antimicrobial agents for S. pneumoniae and concluded that it was 28
5 Susceptibilities of Canadian isolates reliable. Similarly, the Etest has emerged as a reliable susceptibility testing method for the accurate detection of penicillin-resistant S. pneumoniae. Clark et al. 11 compared the Etest with five other methods and reported that it was reliable for detecting penicillin-resistant S. pneumoniae. Some (77) of the isolates used in this study were included in a comparative study of ciprofloxacin and 19 other antimicrobial agents. 12 The low susceptibility of S. pneumoniae to ciprofloxacin reported in that study may relate to the unsuitability of the Microscan panels for testing this pathogen, since recent results reported by Simor et al. 10 indicate that 97% of 1089 isolates were susceptible ( 1 mg/l) to ciprofloxacin when tested by a non-commercial method. We have recently reported that 91% of penicillin-sensitive S. pneumoniae isolates and 91% of penicillin-resistant S. pneumoniae isolates from Saskatchewan were susceptible to ciprofloxacin when tested by Etest and microbroth dilution. 26 M. catarrhalis has increasingly been cited in the literature as a pathogen associated with respiratory tract infections. 3 In our study, 85% of M. catarrhalis were β- lactamase-positive and resistant to penicillin. This finding is consistent with previously published results 15,27 and slightly higher than those reported by Hoban et al. 16 from five North American centres. Although none of the small number of β-lactamase-negative isolates were found to be resistant in this study, the low numbers make interpretation difficult. Other types of resistance mechanisms (non-β-lactamase-mediated), such as alterations in penicillin-binding proteins as in S. pneumoniae and H. influen - zae or changes in permeability, have been reported. 28,29 Our results indicate that while M. catarrhalis resistance to ampicillin is now extensive, susceptibilities to the broader spectrum agents reported here have not changed significantly. The current study measured the susceptibility of selected antimicrobial agents to three separate respiratory tract pathogens. This study adds information on the activity of some antimicrobial agents not tested before in the context of emerging antimicrobial resistance of respiratory pathogens isolated in Canada. Such data will continue to be important in helping clinicians to select the most appropriate microbial agent for the therapy of infected patients. Acknowledgements This work was presented, in part, at the Twentieth International Congress of Chemotherapy, Sydney, Australia, June 30 July 3, This work was funded, in part, by unrestricted grants from Bayer Canada Inc., Glaxo-Wellcome Inc., Lederle Canada Inc., Eli Lilly Canada Inc. and Pfizer Canada Inc. We thank Jonathan Harris and Teresa Tartaglione for editorial contributions. Canadian Respiratory Tract Pathogens Study Group: J. A. Smith, Vancouver General Hospital, Vancouver, British Columbia; M. A. Nobel, University Hospital UBC site, Vancouver, British Columbia; P. Kibsey, Grey Nuns Hospital, Edmonton, Alberta; J. M. Blondeau, St Paul s Hospital, Saskatoon, Saskatchewan; G.B. Horsman, H. E. Robertson Laboratory, Regina, Saskatchewan; D. J. Hoban, Health Sciences Center, Winnipeg, Manitoba; W. D. Colby, University Hospital, London, Ontario; P. Jessamine, Ottawa Civic Hospital, Ottawa, Ontario; A. E. Simor, Sunnybrook Medical Center, Toronto, Ontario; D. E. Low, Mount Sinai Hospital, Toronto, Ontario; A. M. Bourgault, Hôpital Saint-Luc, Montréal, Québec; M. Laverdiere, Hôpital Maisonneuve-Rosemont, Montréal, Québec; M. Kuhn, The Moncton Hospital, Moncton, New Brunswick; S. MacDonald, Halifax Infirmary/Camp Hill Complex, Halifax, Nova Scotia; W. Brown, Health Sciences Center, St John s, Newfoundland. References 1. Scriver, S. R., Walmsley, S. L., Kau, C. L., Hoban, D. J., Brunton, J., McGeer, A. et al. (1994). Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases. Antimicrobial Agents and Chemotherapy 38, Lonks, J. R. & Medeiros, A. A. (1995). The growing threat of antibiotic-resistant Streptococcus pneumoniae. Medical Clinics of North America 79, Catlin, B. W. (1990). Branhamella catarrhalis: an organism gaining respect as a pathogen. Clinical Microbiology Reviews 3, Felmingham, D. (1995). Antibiotic resistance. Do we need new therapeutic approaches? Chest 108, Suppl. 2, 70S 8S. 5. Gruneberg, R. N. & Felmingham, D. (1996). Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagnostic Microbiology and Infectious Disease 25, Kunin, C. M. (1993). Resistance to antimicrobial drugs a worldwide calamity. Annals of Internal Medicine 118, Doern, G. V., Brueggemann, A. B., Pierce, G., Holley, H. P. & Rauch, A. (1997). Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin clavulanate: results of a national multicenter surveillance study. Antimicrobial Agents and Chemotherapy 41, Doern, G. V., Brueggemann, A., Holley, H. P. & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, Doern, G. V., Brueggemann, A. B., Pierce, G., Hogan, T., Holley, H. P. & Rauch, A. (1996). Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, Simor, A. E., Louie, M., Low, D. E. & the Canadian Bacterial 29
6 J. M. Blondeau et al. Surveillance Network. (1996). Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40, Clark, R. B., Giger, O. & Mortensen, J. E. (1993). Comparison of susceptibility test methods to detect penicillin- resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 17, Blondeau, J. M., Yaschuk, Y. & the Canadian Ciprofloxacin Study Group. (1996). Canadian ciprofloxacin susceptibility study: comparative study from 15 medical centers. Antimicrobial Agents and Chemotherapy 40, National Committee for Clinical Laboratory Standards. (1994). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A7. NCCLS, Villanova, PA. 14. Tremblay, L. D., L Ecuyer, J., Provencher, P., Bergeron, M. G. & the Canadian Study Group. (1990). Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Medical Association Journal 143, Hoban, D. J., Jones, R. N. & the Canadian Ofloxacin Study Group. (1995). Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Chemotherapy 41, Hoban, D. J., Jones, R. N., Harrell, L. J., Knudson, M. & Sewell, D. (1993). The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance. Diagnostic Microbiology and Infectious Disease 17, Baer, M., Vuento, R. & Vesikari, T. (1995). Increase in bacteraemic pneumococcal infections in children. Lancet 345, Foster, J. A. & McGowan, K. L. (1994). Rising rate of pneumococcal bacteremia at the Children s Hospital of Philadelphia. Pediatric Infectious Disease Journal 13, Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Disease 15, Barry, A. L., Pfaller, M. A., Fuchs, P. C. & Packer, R. R. (1994). In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US Medical Centers in 1992 and Antimicrobial Agents and Chemotherapy 38, Breiman, R. F., Butler, J. C., Tenover, F. C., Elliott, J. A. & Facklam, R. R. (1994). Emergence of drug-resistant pneumococcal infections in the United States. Journal of the American Medical Association 271, Dixon, J. M., Lipinski, A. E. & Graham, M. E. (1977). Detection and prevalence of pneumococci with increased resistance to penicillin. Canadian Medical Association Journal 117, Jette, L. P. & Lamothe, F. (1989). Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. Journal of Clinical Microbiology 27, Mazzulli, T., Simor, A. E., Jaeger, R., Fuller, S. & Low, D. E. (1990). Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 34, Jacobs, M. R., Bajaksouzian, S., Appelbaum, P. C. & Bolmstrom, A. (1992). Evaluation of the Etest for susceptibility testing of pneumococci. Diagnostic Microbiology and Infectious Disease 15, Blondeau, J. M., Vaughan, D., Low, D., Graham, C. & Sutor, M. (1997). Regional resistance rates for penicillin resistant Streptococcus pneumoniae (PRSP) in Saskatchewan, Canada. In Proceedings of the Twentieth International Congress of Chemotherapy, Sydney, Abstract P , p. 80. Organizing Committee of the International Congress of Chemotherapy, Victoria, Australia. 27. Felmingham, D. & Gruneberg, R. N. (1996). A multicentre collaborative study of the antimicrobial susceptibility of communityacquired, lower respiratory tract pathogens : the Alexander Project. Journal of Antimicrobial Chemotherapy 38, Suppl. A, Quinn, J. P. (1989). Mechanism of resistance to beta-lactam antibiotics. Hospital Formulary 24, Hakenbeck, R., Tarpay, M. & Tomasz, A. (1980). Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 17,
Annual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)
Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood
More informationORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA
ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton
More informationMarc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium
AAC Accepts, published online ahead of print on April 0 Antimicrob. Agents Chemother. doi:./aac.0001- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.
ORIGINAL ARTICLE Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997 98 I. A. Critchley 1, C. Thornsberry
More informationand Health Sciences, Wayne State University and Detroit Receiving Hospital, Detroit, MI, USA
Journal of Antimicrobial Chemotherapy (2004) 54, Suppl. S1, i7 i15 DOI: 10.1093/jac/dkh313 JAC Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae
More informationBrief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot
More informationSUPPLEMENT ARTICLE. among clinical isolates of S. pneumoniae in the United
SUPPLEMENT ARTICLE Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062
More informationChristiane Gaudreau* and Huguette Gilbert
Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter
More informationResistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints
...PRESENTATIONS... Resistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints Angela B. Brueggemann, MS; and Gary V. Doern, PhD Presentation Summary Streptococcus pneumoniae
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationBacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota
Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationJan A. Jacobs* and Ellen E. Stobberingh
Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationMicrobiology, Southmead Hospital, Southmead Road, Bristol BS10 5NB, UK
Journal of Antimicrobial Chemotherapy (2008) 62, Suppl. 2, ii97 ii103 doi:10.1093/jac/dkn356 Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory
More informationTreatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani
Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani 30-1-2018 1 Objectives of the lecture At the end of lecture, the students should be able to understand the following:
More informationKeywords: amoxicillin/clavulanate, respiratory tract infection, antimicrobial resistance, pharmacokinetics/pharmacodynamics, appropriate prescribing
Journal of Antimicrobial Chemotherapy (2004) 53, Suppl. S1, i3 i20 DOI: 10.1093/jac/dkh050 Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review
More informationClinical efficacy of cefpodoxime in respiratory tract infection
Journal of Antimicrobial Chemotherapy (2002) 50, Topic T1, 23 27 DOI: 10.1093/jac/dkf805 Clinical efficacy of cefpodoxime in respiratory tract infection Robert Cohen* Department of Microbiology, Intercommunal
More informationVersion 1.01 (01/10/2016)
CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationPrinciples and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013
Principles and Practice of Antimicrobial Susceptibility Testing Microbiology Technical Workshop 25 th September 2013 Scope History Why Perform Antimicrobial Susceptibility Testing? How to Perform an Antimicrobial
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationCiprofloxacin, Enoxacin, and Ofloxacin against Aerobic and
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1988, p. 1143-1148 Vol., No. 8 0066-4804/88/081143-06$00/0 Copyright 1988, American Society for Microbiology Comparative Activities of, Amoxicillin-Clavulanic
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationUse of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2000, p. 3341 3348 Vol. 38, No. 9 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Use of the National Committee for
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationDisk Diffusion Susceptibility Testing of Branhamella catarrhalis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1987, p. 1519-1523 Vol. 31, No. 10 0066-4804/87/101519-05$00/0 Copyright 1987, American Society for Microbiology Disk Diffusion Susceptibility Testing of Branhamella
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More informationQuality assurance of antimicrobial susceptibility testing
Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More information...CONTINUING MEDICAL EDUCATION...
...CONTINUING MEDICAL EDUCATION...... Drug Resistance and the Treatment of Upper Respiratory Infections GOAL To provide comprehensive and up-to-date information concerning drug resistance and the implications
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationSAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion
More informationAntibacterial susceptibility testing
Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several
More informationGeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007
GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure
More informationEmergence of Antibiotic Resistance in Upper and
...PRESENTATIONS... Emergence of Antibiotic Resistance in Upper and Lower Respiratory Tract Infections Michael R. Jacobs, MB, BCh, PhD Presentation Summary The increase in antibiotic resistance is of great
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationEDUCATIONAL COMMENTARY CURRENT METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING
Commentary provided by: Linsey Donner, MPH, CPH, MLS (ASCP) CM Assistant Professor, Microbiology and Serology College of Allied Health Professions, Division of Medical Laboratory Science University of
More informationShould we test Clostridium difficile for antimicrobial resistance? by author
Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first
More informationACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective
ACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective Antwerpen 8 november 2002 Yvan Valcke MD PhD AZ Maria Middelares Sint-Niklaas ACUTE EXACERBATIONS of COPD (AE-COPD) Treatment of AECB Role
More informationparameters were enhanced to develop new antimicrobial formulations CONSIDERATIONS IN ANTIMICROBIAL SELECTION Using animal models and human data, PK an
Overview of Newer Antimicrobial Formulations for Overcoming Pneumococcal Resistance William A Craig, MD The pharmacokinetic (PK) and pharmacodynamic (PD) profile of an antimicrobial agent provides important
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationThe World Health Organization has referred to. Antibiotic Resistance: The Iowa Experience DRUG UTILIZATION. Nancy Bell, RPh
DRUG UTILIZATION Antibiotic Resistance: The Iowa Experience Nancy Bell, RPh Background: In the past 10 years, the number of strains of Streptococcus pneumoniae and other common respiratory pathogens that
More informationAntimicrobial Resistance Trends in the Province of British Columbia
655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2443 Fax 604.707.2441 www.bccdc.ca Antimicrobial Resistance Trends in the Province of British Columbia 2013 Prepared by the Do Bugs Need Drugs? Program
More informationPushpa Bhawan Mal 1, Kauser Jabeen 1*, Joveria Farooqi 1, Magnus Unemo 2 and Erum Khan 1
Mal et al. BMC Microbiology (2016) 16:236 DOI 10.1186/s12866-016-0707-6 RESEARCH ARTICLE Open Access Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared
More informationIn Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationCLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014
vs. Olga Perovic, Principal Pathologist, Center for Opportunistic, Tropical and Hospital Infections, Associate Professor at WITS, Saturday, May 24, 2014 A not-for-profit membership organization, the Clinical
More information10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)
Beta-lactam antibiotics Penicillins Target - Cell wall - interfere with cross linking Actively growing cells Bind to Penicillin Binding Proteins Enzymes involved in cell wall synthesis Activity of an Antibiotic
More informationReceived 10 February 2009/Returned for modification 14 April 2009/Accepted 14 May 2009
JOURNAL OF CLINICAL MICROBIOLOGY, July 2009, p. 2187 2193 Vol. 47, No. 7 0095-1137/09/$08.00 0 doi:10.1128/jcm.00304-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Development
More informationAntibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections
Vol.1 No.2 Oct-Dec 2013 ISSN : 2321-6387 Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections S. Yogeshpriya*, Usha N.Pillai, S. Ajithkumar and N. Madhavan Unny Department
More informationANTIMICROBIAL SUSCEPTIBILITY IN COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA IN ADULTS. S. KARIUKI, J. MUYODI, B. MIRZA, W. MWATU and J.J.D.
April 2003 EAST AFRICAN MEDICAL JOURNAL 213 East African Medical Journal Vol. 80 No 4 April 2003 ANTIMICROBIAL SUSCEPTIBILITY IN COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA IN ADULTS S. Kariuki, PhD, J. Muyodi,
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationAntimicrobial susceptibility of Salmonella, 2016
susceptibility of Salmonella, 06 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based surveillance
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationAntibiotics & treatment of Acute Bcterial Sinusitis. Walid Reda Product Manager. Do your antimicrobial options meet your needs?
Antibiotics & treatment of Acute Bcterial Sinusitis Walid Reda Product Manager Do your antimicrobial options meet your needs? Antimicrobial Effects: What s involved? Effect in Humans: Serum concentration
More informationIn vitro Activity of Gemifloxacin Against Recent Clinical Isolates of Bacteria in Korea
J Korean Med Sci 2002; 17: 737-42 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences In vitro Activity of Gemifloxacin Against Recent Clinical Isolates of Bacteria in Korea Gemifloxacin is
More informationMethicillin resistant Staphylococcus aureus : a multicentre study
Methicillin resistant Staphylococcus aureus : a multicentre study S. Hafiz ( Mid-East Medical Center,Karachi. ) A. N. Hafiz ( Mid-East Medical Center, Karachi. ) L. Ali ( City Medical Laboratory, Peshawer,
More informationFailure of Cloxacillin in a Patient with BORSA Endocarditis ACCEPTED
JCM Accepts, published online ahead of print on 30 December 2008 J. Clin. Microbiol. doi:10.1128/jcm.00571-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationChoosing the Ideal Antibiotic Therapy and the Role of the Newer Fluoroquinolones in Respiratory Tract Infections
...CLINICIAN INTERVIEW... Choosing the Ideal Antibiotic Therapy and the Role of the Newer Fluoroquinolones in Respiratory Tract Infections An interview with Robert C. Owens, Jr., PharmD, Clinical Pharmacy
More informationMonitoring gonococcal antimicrobial susceptibility
Monitoring gonococcal antimicrobial susceptibility The rapidly changing antimicrobial susceptibility of Neisseria gonorrhoeae has created an important public health problem. Because of widespread resistance
More informationOver 40 Posters/Abstracts in Support of TREK Presented at the 2004 ECCMID
Over 40 Posters/Abstracts in Support of TREK Presented at the ECCMID This was our best ECCMID ever for TREK presentations! The following posters and abstracts were in support of TREK products! Sensititre
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationDECREASED SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE TO FLUOROQUINOLONES IN CANADA
DECREASED SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE TO FLUOROQUINOLONES IN CANADA DANNY K. CHEN, M.D., ALLISON MCGEER, M.D., JOYCE C. DE AZAVEDO, PH.D., AND DONALD E. LOW, M.D., FOR THE CANADIAN BACTERIAL
More informationPractical approach to Antimicrobial susceptibility testing (AST) and quality control
Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationModeling the Emergence of Multidrug Antibiotic Resistance
ISDC 2001 - Atlanta, USA Modeling the Emergence of Multidrug Antibiotic Resistance Jack Homer, Ph.D Homer Consulting James Jorgensen, Ph.D Prof. of Pathology & Medicine Univ. of Texas, San Antonio Kate
More informationDefining Resistance and Susceptibility: What S, I, and R Mean to You
Defining Resistance and Susceptibility: What S, I, and R Mean to You Michael D. Apley, DVM, PhD, DACVCP Department of Clinical Sciences College of Veterinary Medicine Kansas State University Susceptible
More informationAntibiotic Resistance: Multi-Drug Profiles and Genetic Determinants.
East Tennessee State University Digital Commons @ East Tennessee State University Electronic Theses and Dissertations 12-2001 Antibiotic Resistance: Multi-Drug Profiles and Genetic Determinants. LaShan
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More informationANTIMICROBIAL SUSCEPTIBILITY DETECTION OF ELEVATED MICs TO PENICILLINS IN β- HAEMOLYTIC STREPTOCOCCI
HAEMOLYTIC STREPTOCOCCI This specimen was designated as a sample from a skin wound that was to be cultured, identified to species level and susceptibility tested [1-3]. The culture contained a Streptococcus
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationAntibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Antibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Sung Kyu Kim, M.D.Young Sam Kim, M.D. Department of Internal Medicine Yonsei University College of Medicine,
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More information